EVALUATION OF ANTICANCER EFFECT OF BRASSICA RAPA CHINENSIS LINN. USING IN VIVO MODEL

Aim: Dalton’s Lymphoma Ascites cells (DLA) are a cancer of the lymphocytes, a type of cell that forms part of the immune system. The present study aims to evaluate the anticancer effect of methanolic extract of bokchoy (Brassica rapa Chinensis leaves) using in vivo model in mice. Methods: The experimental mice were divided to 5 groups. The methanolic extract (800 mg/kg) and nanoparticles of methanolic extract (1mg/kg) of Brassica rapa Chinensis leaves, was administered to mice of group III and IV respectively. The mice were induced with DLA. Group I mice served as normal control and group II as DLA control. Cyclophosphamide at 3mg/kg b.wt was administered to group V. Results: Treatment with methanolic extract and nanoparticles of methanolic extract of Brassica rapa Chinensis leaves (800, 1mg/kg, orally) against Dalton’s Lymphoma  Ascites (DLA) in mice by the activities of marker enzymes as Aspartate transaminase (AST), Alanine transaminase (ALT), Alkanine phosphatase (ALP), Acid phosphatase (ACP), Lactate dehydrogenase (LDH), γ Glutamyl transpeptidase (γGT), 5’Nucleotidase, β-D-Glucuronidase, β-D-Galactosidase and Cathepsin D levels in serum. The extract also enhanced in a dose dependent manner with 3mg dose revealing more defending effect in line with the standard drug, Cyclophosphamide. Conclusion: The observed results indicate that the Brassica rapa Chinensis leaves extract at both the doses were effective in curbing the toxic insult of DLA.